Preliminary feasibility of SHURUI single-port robot-assisted radical cystectomy with exploratory comparison to a contemporaneous da Vinci Xi single-port cohort.

Abstract

Background: Single-port robot-assisted surgery represents the latest advancement in minimally invasive urological oncology. The SHURUI single-port (SP) surgical robot system recently received approval as a second SP system and as alternative to the Da Vinci platform. We report the first comparison of the two systems in radical cystectomy patients.

Methods: We conducted a retrospective comparative study at a tertiary referral center comparing operative and oncological outcomes in consecutive patients with bladder cancer who underwent single incision radical cystectomy using either the SHURUI SP-SR system or the Da Vinci Xi system.

Results: We treated eleven patients using the SHURUI SP-SR system and 24 patients using the Da Vinci Xi system. We successfully completed all procedures without conversion. Baseline characteristics were generally similar between groups, and short-term perioperative, postoperative recovery, complication, and pathological outcomes were broadly comparable. No unexpected safety concerns were identified. Study limitations include small sample size, single-surgeon experience, retrospective design, and short follow-up.

Conclusions: We demonstrated that in the first experiences SHURUI SP achieves comparable perioperative safety and efficacy to Da Vinci Xi for single incision radical cystectomy. Our findings support SHURUI as a potential alternative, potentially expanding robotic surgery access.